Rhythm Pharmaceuticals, Inc. (RYTM) Social Stream
Featured Post From StockTwits About RYTM
$RYTM "Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity (GlobeNewswire)MrTilt, published August 10, 2021
Have any of you guys read about the RA capital backed Swedish listed company Saniona? Saniona and Rhythm will probably be the main competitors in the Hypothalamic Obesity field.
Saniona has great results both in Prader-Willi syndrome as well as in Hypothalamic Obesity and Orphan Drug Designation in both indications. Saniona is so far the only company that has received Orphan drug designation in Hypothalamic Obesity.
It´s also the only company currently active in the Prader-Willi field that has shown weight loss in Prader-Willi patients with it´s lead aset Tesomet. Market cap below 150 million USD listed on Nasdaq Sweden OMX - SANION, Saniona, (SE0005794617).